JPMorgan raised the firm’s price target on Delek US (DK) to $35 from $19 and keeps a Neutral rating on the shares as part of a Q3 earnings preview. The firm established a December 2026 target versus December 2025 previously. Delek has made operational and cost improvements through its refinery reliability projects, the analyst tells investors in a research note.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US Holdings: Hold Rating Maintained Amid Modest EBITDA Growth and Stable Margins
- Delek US price target raised to $33 from $20 at Scotiabank
- Delek US upgraded to Equal Weight from Underweight at Morgan Stanley
- TD upgrades Delek US to Hold on EPA refinery exemption
- Delek US upgraded to Hold from Sell at TD Cowen